Prediction of Prognosis of Estrogen Receptor-positive Breast Cancer with Combination of Selected Estrogen-regulated Genes

Overview

Journal Cancer Sci

Specialty Oncology

Date 2004 Jun 9

PMID 15182430

Citations 32

Authors

Nobuyuki Yoshida

Yoko Omoto

Akio Inoue

Hidetaka Eguchi

Yasuhito Kobayashi

Masafumi Kurosumi

Shigehira Saji

Kimito Suemasu

Tomoki Okazaki

Kei Nakachi

Toshiro Fujita

Shin-Ichi Hayashi

Affiliations

Soon will be listed here.

Abstract

Estrogen receptor (ER)-positive breast cancer is a distinct subpopulation of breast cancer exhibiting a high response rate to endocrine therapy. However, not all ER-positive patients respond to the therapy, and a subgrouping of ER-positive patients based on the physiology of estrogen signaling is expected to be useful for predicting the prognosis. This study has revealed that selected estrogen-regulated genes (ERGs) are useful in identification of a poor-prognosis population among ER-positive breast cancer patients. First, the expression levels of 11 ERGs, selected based on our earlier microarray study in cultured cells, were analyzed by means of real-time reverse transcription-PCR in 14 ER-positive human breast cancer tissues. The patients were clearly divided into two groups in cluster analysis. Then, we examined the expression levels of two representative ERGs, histone deacetylase 6 (HDAC6) and insulin-like growth factor binding protein 4 (IGFBP-4), in 62 ER-positive patients with immunohistochemistry to assess the impact of ERG expression on prognosis (median follow-up 4409 days). Positive HDAC6 staining was significantly correlated with a lower disease-free survival rate. Moreover, when the expression level of HDAC6 was assessed in combination with IGFBP-4 expression in the nucleus, the poor-prognosis patients were more accurately identified. This study has identified new candidate ERGs for prediction of prognosis, and we suggest that combined assessment of the expression levels of these ERGs will contribute to the clinically useful stratification of ER-positive breast cancer patients.

Citing Articles

SARS-CoV-2 nucleocapsid protein promotes self-deacetylation by inducing HDAC6 to facilitate viral replication.

Mukherjee A, Lo M, Chandra P, Datta Chaudhuri R, De P, Dutta S Virol J. 2024; 21(1):186.

PMID: 39135075 PMC: 11321199. DOI: 10.1186/s12985-024-02460-5.

2-Methoxyestradiol as an Antiproliferative Agent for Long-Term Estrogen-Deprived Breast Cancer Cells.

Hirao-Suzuki M, Kanameda K, Takiguchi M, Sugihara N, Takeda S Curr Issues Mol Biol. 2023; 45(9):7336-7351.

PMID: 37754248 PMC: 10527823. DOI: 10.3390/cimb45090464.

Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.

Chuang H, Hsu J, Chang H, Wang P, Wei P, Wu D Int J Med Sci. 2020; 17(17):2635-2643.

PMID: 33162791 PMC: 7645340. DOI: 10.7150/ijms.50097.

Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.

Lee Y, Kim S, Park R, Kim Y Viruses. 2020; 12(5).

PMID: 32443734 PMC: 7291177. DOI: 10.3390/v12050565.

MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer.

Yang Y, Sun Y, Wang H, Li H, Zhang M, Zhou L Oncol Lett. 2018; 16(6):7295-7301.

PMID: 30546469 PMC: 6256293. DOI: 10.3892/ol.2018.9513.

References

J van t Veer L, Dai H, van de Vijver M, He Y, Hart A, Mao M . Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530-6. DOI: 10.1038/415530a. View

Liu B, Lee H, Weinzimer S, Powell D, Clifford J, Kurie J . Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 2000; 275(43):33607-13. DOI: 10.1074/jbc.M002547200. View

Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R . Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol. 2002; 29(2):175-92. DOI: 10.1677/jme.0.0290175. View

West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R . Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A. 2001; 98(20):11462-7. PMC: 58752. DOI: 10.1073/pnas.201162998. View

Eisen M, Spellman P, Brown P, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998; 95(25):14863-8. PMC: 24541. DOI: 10.1073/pnas.95.25.14863. View

Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98(19):10869-74. PMC: 58566. DOI: 10.1073/pnas.191367098. View

Hayashi S, Tanimoto K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K . Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res. 1997; 57(10):1981-5. View

Amaar Y, Thompson G, Linkhart T, Chen S, Baylink D, Mohan S . Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem. 2002; 277(14):12053-60. DOI: 10.1074/jbc.M110872200. View

Welcsh P, Lee M, Black D, Mahadevappa M, Swisher E, Warrington J . BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A. 2002; 99(11):7560-5. PMC: 124283. DOI: 10.1073/pnas.062181799. View

10.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

11.

Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, Rees C . Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. DOI: 10.1038/35021093. View

12.

Maxwell P, van den Berg H . Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines. Cancer Lett. 1999; 139(2):121-7. DOI: 10.1016/s0304-3835(99)00009-9. View

13.

Dalton L, Page D, Dupont W . Histologic grading of breast carcinoma. A reproducibility study. Cancer. 1994; 73(11):2765-70. DOI: 10.1002/1097-0142(19940601)73:11<2765::aid-cncr2820731119>3.0.co;2-k. View

14.

Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R . Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet. 2000; 9(20):2981-91. DOI: 10.1093/hmg/9.20.2981. View

15.

Gruvberger S, Ringner M, Chen Y, Panavally S, Saal L, Borg A . Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001; 61(16):5979-84. View

16.

Verdel A, Khochbin S . Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J Biol Chem. 1999; 274(4):2440-5. DOI: 10.1074/jbc.274.4.2440. View

17.

Grozinger C, Hassig C, Schreiber S . Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A. 1999; 96(9):4868-73. PMC: 21783. DOI: 10.1073/pnas.96.9.4868. View

18.

Baum M . A vision for the future?. Br J Cancer. 2002; 85 Suppl 2:15-8. PMC: 2375171. DOI: 10.1054/bjoc.2001.1984. View

19.

Omoto Y, Kobayashi Y, Nishida K, Tsuchiya E, Eguchi H, Nakagawa K . Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun. 2001; 285(2):340-7. DOI: 10.1006/bbrc.2001.5158. View

20.

Ciocca D, Elledge R . Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocrine. 2000; 13(1):1-10. DOI: 10.1385/ENDO:13:1:1. View